FDA.reportPublic FDA data

Application 202462

Type
ANDA
Sponsor
SAGENT PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CHLOROTHIAZIDE SODIUMCHLOROTHIAZIDE SODIUMINJECTABLE;INJECTIONEQ 500MG BASE/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25021-305chlorothiazide sodiumchlorothiazide sodiumSagent PharmaceuticalsANDACurrent
25021-305chlorothiazide sodiumchlorothiazide sodiumSagent PharmaceuticalsANDACurrent
25021-305chlorothiazide sodiumchlorothiazide sodiumSagent PharmaceuticalsANDACurrent
25021-305chlorothiazide sodiumchlorothiazide sodiumSagent PharmaceuticalsANDACurrent
25021-305chlorothiazide sodiumchlorothiazide sodiumSagent PharmaceuticalsANDACurrent
25021-305chlorothiazide sodiumchlorothiazide sodiumSagent PharmaceuticalsANDACurrent